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Key points
 Acute inflammation engages various descending control systems in the brain that alter the
resulting inflammatory pain, usually by inhibiting it.
 In this study we looked at the differences in inhibition of acute (up to 3 h) inflammatory pain
from smooth (glabrous) and hairy skin in the rat hind foot.
 In hairy skin, inflammatory pain is rapidly inhibited by descending systems that release
noradrenaline, but not opiates, into the spinal cord.
 In glabrous skin, neither descending noradrenergic nor opioidergic controls affect
inflammatory pain.
 These results tell us that the controls on the spinal processing of cutaneous inflammatory pain
differ according to the skin type affected.
Abstract Descending controls of spinal nociceptive processing play a critical role in the
development of inflammatory hyperalgesia. Acute peripheral nociceptor sensitization drives
spinal sensitization and activates spino–supraspinal–spinal loops leading to descending inhibitory
and facilitatory controls of spinal neuronal activity that further modify the extent and degree of
the pain state. The afferent inputs from hairy and glabrous skin are distinct with respect to
both the profile of primary afferent classes and the degree of their peripheral sensitization. It is
not known whether these differences in afferent input differentially engage descending control
systems to different extents or in different ways. Injection of complete Freund’s adjuvant resulted
in inflammation and swelling of hairy hind foot skin in rats, a transient thermal hyperalgesia
lasting <2 h, and longlasting primary mechanical hyperalgesia (7 days). Much longer lasting
thermal hyperalgesia was apparent in glabrous skin (1 h to >72 h). In hairy skin, transient
hyperalgesia was associated with sensitization of withdrawal reflexes to thermal activation of
either A- or C-nociceptors. The transience of the hyperalgesia was attributable to a rapidly
engaged descending inhibitory noradrenergic mechanism, which affected withdrawal responses
to both A- and C-nociceptor activation and this could be reversed by intrathecal administration
of yohimbine (α-2-adrenoceptor antagonist). In glabrous skin, yohimbine had no effect on
an equivalent thermal inflammatory hyperalgesia. We conclude that acute inflammation and
peripheral nociceptor sensitization in hind foot hairy skin, but not glabrous skin, rapidly activates
a descending inhibitory noradrenergic system. Thismay result fromdifferences in the engagement
of descending control systems following sensitization of different primary afferent classes that
innervate glabrous and hairy skin.
C© 2014 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society. DOI: 10.1113/jphysiol.2013.266494
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution
and reproduction in any medium, provided the original work is properly cited.
3612 R. A. R. Drake and others J Physiol 592.16
(Received 8 January 2014; accepted after revision 25 May 2014; first published online 30 May 2014)
Corresponding author B. M. Lumb: School of Physiology and Pharmacology, University of Bristol, Medical Sciences
Building, University Walk, Bristol BS7 8EJ, UK. Email: B.M.Lumb@bristol.ac.uk
Abbreviations CFA, complete Freund’s adjuvant; LC, locus coeruleus; PAG, periaqueductal grey; RVM, rostroventral
medulla.
Introduction
Tissue damage and subsequent inflammation activate and
sensitize peripheral nociceptors. This increases afferent
input to central nociceptive circuits and leads to enhanced
sensitivity to nociceptive stimuli (hyperalgesia), and
sensations of pain to innocuous stimulation (allodynia)
(Meyer et al. 2005; Latremoliere & Woolf, 2009). Peri-
pheral nociceptive inputs drive both the sensitization of
spinal nociceptive circuits and the activation of ascending
and descending pathways that together modulate trans-
mission, and ultimately perception, of nociceptive
information (Mantyh&Hunt, 2004). The final perception
of the intensity and quality of pain is determined by the
degree of suchmodulation of information throughout the
nociceptive neuraxis (Ossipov et al. 2010).
It is well established that spinal nociceptive processing is
modulated by both inhibitory and facilitatory descending
pathways that originate supraspinally (Millan, 2002).
The midbrain periaqueductal grey (PAG) forms a
major component of the descending nociceptive system
and relays via brainstem nuclei such as the locus coeruleus
(LC) and the rostroventral medulla (RVM) (Mantyh,
1983; Bajic & Proudfit, 1999) to exert controls on
spinal nociceptive neurons. Descending controls from
the PAG include opioidergic (Vasquez & Vanegas, 2000;
Przewłocki & Przewłocka, 2001; Kwok et al. 2013) and
monoaminergic (Pertovaara, 2006) inhibition, as well as
prostanergic facilitation (Oliva et al. 2006; Leith et al. 2007;
Palazzo et al. 2011). Medullary and brainstem nuclei are
major sources of spinally projectingmonoaminergic fibres
(Westlund et al 1983; Yoshimura & Furue, 2006) that are
known to exert inhibitory influences, which modulate the
development of acute and persistent pain states (Vanegas
& Schaible, 2004; Pertovaara, 2006, 2013; Yoshimura
& Furue, 2006). Descending noradrenergic systems
exert these inhibitory influences largely through pre-
synaptic inhibition, primarily through α-2-adrenoceptor
activation (Pertovaara, 2006; Yoshimura & Furue, 2006).
α-2-Agonists, in particular those with affinity for α-2A
receptors, are antinociceptive in both animals and humans
(Pertovaara, 2006). Descending serotonergic systems exert
complex pro- and antinociceptive effects at the spinal
level, primarily through 5-HT1 and 5-HT3 receptors
(Yoshimura & Furue, 2006; Dogrul et al. 2009; Jeong
et al. 2012). Additionally, there are peripheral sources
of monoamines, such as sympathetic fibres within the
dorsal root ganglia, that are able to impact upon
nociception during periods of prolonged inflammation
or tissue damage (Pertovaara, 2006). Peripheral nerve
stimulation evokes spinal release of monoamines in the
presence of ganglionic blocking agents (Tyce & Yaksht,
1981), however, and thus it is widely accepted that the
major sources of spinal noradrenaline and serotonin
are projections from medullary and brainstem nuclei
(Pertovaara, 2006; Yoshimura & Furue, 2006).
Acute cutaneous inflammation leads to sensitization of
peripheral and central nociceptive neurons, resulting in
primary and secondary hyperalgesia. Descending controls
of the spinal processing of input from the area of primary
hyperalgesia are initially facilitatory from, for example
PAG/RVM, but are short-lived (up to 3 h), and are then
overwhelmed by local spinal and supraspinal inhibitory
influences (Ren & Dubner, 1996; Guan et al. 2002; Miki
et al. 2002; Vanegas & Schaible, 2004). The dampening
effect of the inhibitory systems on spinal dorsal horn
activity effectively reduces the extent of inflammatory
pain by limiting central sensitization (Vanegas & Schaible,
2004).
Current understanding of the development of
inflammatory hyperalgesia and the influence of
descending controls over spinal nociceptive processing is
largely derived from animal models using inflammatory
insults to the glabrous skin of the hind limb. There
is little information on the contribution of descending
controls to the development or maintenance of primary
hyperalgesia in hairy skin, which is a potential
shortcoming given this is the more prevalent skin type in
mammals.Glabrous cutaneous tissue foundon the plantar
surface of the foot forms a major informative surface of
the body providing critical sensory and discriminative
information about the environment. This is reflected
by a greater density of primary afferents innervating
glabrous tissue and its over-representation in cortical
somatotopic maps (Blake et al. 2002; Provitera et al.
2007; Boada et al. 2013). There are notable differences in
the profiles of nociceptive afferent fibres that innervate
glabrous and hairy cutaneous tissue: for instance,
a three-fold higher proportion of fast-conducting to
slowly conducting fibres innervates glabrous cutaneous
tissue (Boada et al. 2013), and a large proportion of
C-polymodal nociceptors innervate the hairy skin of
the rat hind foot (Lynn & Carpenter, 1982; Leem et al.
1993). Critically, there are differences in the sensitization
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of unmyelinated nociceptive afferents innervating the
two skin types. Following application of conditioning
stimuli or sensitizing agents, a population of polymodal
C-nociceptors found in glabrous skin fail to sensitize
to thermal stimuli, but a similar population of poly-
modal C-nociceptors found in hairy cutaneous tissue do
sensitize, with a lowering of activation threshold and/or
increased suprathreshold response (Campbell & Meyer,
1983; Andrew&Greenspan, 1999; Koerber et al. 2010).We
hypothesized that during inflammation, the differences in
primary afferent input from different skin types might
differentially drive descending control systems and hence
differentially affect the development of inflammatory
hyperalgesia in the two skin types.
Methods
All experiments were performed in accordance with
the UK Animals (Scientific Procedures) Act (1986) and
associated guidelines. Animals were housed in standard
conditions with food and water provided ad libitum.
Experiments were performed in a total of 58 male Wistar
rats weighing 250–350 g. Themajority of animals (n= 55)
received a S.C. injection of 50 μg or 100 μg of complete
Freund’s adjuvant (CFA) (1 mg ml−1; cat. no. F5881;
Sigma-Aldrich Co. Ltd, Gillingham, UK) into either the
dorsal or ventral surface of the left hind foot under brief
halothane (3% inO2) anaesthesia. Control animals (n= 3)
received a S.C. injection of an equivalent volume of vehicle
(mineral oil). CFA induces a dose-dependent increase in
swelling, in both rat andmouse, up to doses of 250μg and
500μg, respectively. This CFA dose/volume (50μg/50μl)
gives a mild, limited inflammation that is less than the
maximal achievable with CFA, and that does not spread to
involve the sides or other surface of the hind limb. Greater
swelling and spread of inflammation can be seen with
higher doses of CFA (Donaldson et al. 1993; Chillingworth
et al.2006).Althoughdifferences inoedemahavebeenpre-
viously reported with higher CFA doses (Cook & Moore,
2006), we chose to investigate the effects of equivalent
inflammatory stimuli in this study, rather than equivalent
oedematous responses.
Nociceptive behavioural testing
To assess the effect of S.C. CFA injections at different sites
on nociceptive behaviour, some animals (n = 7) under-
went nociceptive testing before and at 3 h and 1 day,
3 days and 7 days after either dorsal or plantar S.C. CFA
injection. Animals were habituated to the apparatus and
experimenter beginning 3 days prior to the start of testing.
For mechanical hyperalgesia, serrated laboratory forceps
were adapted with strain gauges for the measurement of
the force applied across the tips (contact area: 5.6 mm2
per tip; total area: 11.2 mm2) (Fig. 1). The output
signal was fed through a bridge amplifier and captured
for subsequent offline analysis via a CED1401 [Cambridge
Electronic Design (CED) Ltd, Cambridge, UK] on a
computer running Spike2 software (CED Ltd). Grams
per volt were calculated following calibration with
standardizedweights placed at the point of finger grip. The
gram force delivered was then divided by the total contact
area to give grams mm−2. The tips were placed across the
dorsoventral aspect of the hind foot and ramped pressure
was applied until the foot was withdrawn or the animal
Figure 1. Apparatus for mechanical stimulation of the hind limb
A, the mechanical stimulator. Strain gauges were attached to both arms of laboratory forceps to allow for the
measurement of force delivered across the tips. The picture of the tips of the forceps shows the area in contact
with the foot (area: 5.6 mm2 for each tip; total: 11.2 mm2). B, digitized trace of raw data showing actual force
applied to the rat hind foot. Withdrawal is marked with input from a foot pedal (top trace), at which point the
withdrawal threshold was determined.
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displayed pain-related behaviours (vocalization, biting,
etc.), at which point the force applied was immediately
stopped. As the duration and force appliedwere controlled
manually, and cut off at thefirst appearance of pain-related
behaviours, the intensity of this stimulus could be
controlled to ensure that it did not result in additional
tissue damage. Use of this stimulator did not result in any
observable tissue damage in naı¨ve or inflamed animals.
The occurrence of withdrawal/response wasmarked using
the input from a foot pedal through the CED1401 into
a computer running Spike2 software. Two consecutive
recordings were made and the mean threshold was
calculated for each animal at each time-point.
To test for thermal hyperalgesia, a custom-built Peltier
heating device (contact area: 18mm2)was used to deliver a
ramped thermal stimulus to the hind foot of the rat from
an initial contact temperature of 30°C. The maximum
temperature was cut off at 55°C to prevent tissue damage.
Surface (contact) temperature was measured with a
T-type thermocouple (made in-house) and captured
for subsequent offline analysis via a CED1401 on a
computer running Spike5 software. Again, the occurance
of withdrawal/response was marked using the input from
a foot peddle through the CED1401 into a computer
running Spike2 software. The extent of limb oedema was
assessed by measuring the thickness across the midline
dorsoventral aspect of the hind foot using callipers before,
and at 1 h, and 1, 3 and 7 days after CFA injection.
Surgical preparation
Surgical preparation for electromyograph (EMG)
recordings was performed under initial halothane
anaesthesia (2–3% in O2) and consisted of: (i) external
jugular branch cannulation for anaesthetic maintenance
[constant I.V. infusion of alphaxalone (40 mg kg h,
Alfaxan; Jurox Pty Ltd, Rutherford, NSW, Australia)];
(ii) external carotid artery branch cannulation for blood
pressure measurement, and (iii) tracheal cannulation for
airway maintenance. Body temperature was maintained
within physiological limits (37–38°C) by means of a
feedback-controlled heating blanket and rectal probe. For
placement of the intrathecal catheter (Størkson et al.
1996), a longitudinal incision was made along the back
midline, starting at the level of the iliac crest and advancing
2–3 cm rostrally. A 6 cm length of 32G polyurethane
catheter (external diameter: 0.25 mm; internal diameter:
0.13 mm) with a manufacturer-supplied internal metal
stylet for increased rigidity (cat. no. 0041; ReCathCo LLC,
Allison Park, PA, USA) was back-loaded into a 25G needle
(Terumo UK Ltd, Egham, Surrey, UK) so that the end
of the catheter was flush with the needle tip. Animals
were positioned with the vertebral column flexed and the
catheter-loaded needle was inserted bevel up between the
L5 and L6 vertebrae until a tail flick indicated penetration
of dura. The catheter was then advanced 3 cm rostrally
along the intrathecal space to approximately the level of
the lumbar enlargement. The needle and stylet were then
carefully removed, leaving in place the catheter, which was
thenfixed in positionwith cyanoacrylate glue (Superglue).
A small (2 cm) length of polyethylene tubing (external
diameter: 6.1 mm; internal diameter: 2.8 mm) was then
attached to the free end of the catheter by inserting the
catheter end just into the polyethylene tubing, which was
then secured with cyanoacrylate, to allow for connection
to a Hamilton syringe for drug delivery.
For the measurement of EMG activity, a bi-polar
electrode was custom-made using Teflon-coated stainless
steel wires (0.075 mm diameter; Advent Research
Materials, Eynsham, Oxford, UK) that were stripped at
both ends; one end was inserted into the bicep femoris of
the hind limb using a 25-gauge hypodermic needle. The
signal across the electrodes was amplified (×1k, Neuro-
log NL104 amplifier, A-B configuration; Digitimer Ltd,
LetchworthGardenCity, UK) and filtered (50Hz to 5 kHz,
Neurolog NL125) and raw data were digitized via the
CED1401 and stored for offline analysis using Spike2.
Animals were left under a constant level of anaesthesia for
aminimumof 1 h after surgical preparation before further
experiments. The level of anaesthesia was maintained
by constant infusion such that EMG activity could be
detected in response to stimulation without overt limb
movement.
Preferential activation of A- and C-heat nociceptors
A- and C-nociceptors were preferentially activated
using a custom-made heat lamp in contact with the
dorsal hind foot. A constant voltage was applied to
the lamp to provide fast (7.5 ± 1°C s−1) or slow
(2.5 ± 1°C s−1) rates of heating, which preferentially
activate A-fibre (myelinated, capsaicin-insensitive)
and C-fibre (unmyelinated, capsaicin-sensitive) heat
nociceptors, respectively (Yeomans & Proudfit, 1996;
McMullan et al. 2004; McMullan & Lumb, 2006a; Leith
et al. 2007). Stimuli were applied with an inter-stimulus
interval of 8 min to prevent tissue damage and
sensitization. The heat ramp apparatus was placed in
contact with the foot for a minimum of 60 s before the
start of the heat stimulation to allow for adaptation of
low-threshold mechanoreceptors. A feedback-controlled
cut-off was set at 58°C for fast thermal ramps and at
55°C for slow thermal ramps to prevent tissue damage. In
recordings in which thermal ramps reached the cut-off
temperature without the occurrence of measurable
EMG activity, threshold was recorded as cut-off +2°C
(Leith et al. 2007). For stimulation of glabrous skin, a
slow ramp (2.5 ± 1°C s−1) contact heat stimulus was
applied immediately behind the footpad using the same
apparatus. As it has not yet been determined whether
C© 2014 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society.
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this stimulus is able to preferentially activate A- or
C-nociceptors in glabrous skin, no attempt was made to
draw conclusions on A- or C-nociceptor activation at this
site.
Subsurface heating rate measurement
To determine whether CFA-induced foot oedema affected
the subcutaneous heating rates required for preferential
activation of A- and C-nociceptors, subcutaneous heating
rates were directly measured using a T-type thermo-
couple. Heating rates were recorded before, for 3 h and
on day 7 after S.C. CFA injection. Care was taken to
implant the thermocouple as closely as possible to the
dermal–epidermal junction as nociceptive terminals are
found in the epidermis and superficial dermal layers. Two
ramps were delivered at each experimental time-point.
Drugs
The α-2-adrenoreceptor antagonist yohimbine 30 μg in
10 μl in vehicle (80% saline, 20% DMSO, cat. no. 1127;
Tocris Biosciences, Bristol,UK)was delivered intrathecally
via the implanted catheter 2.5 h after CFA (n = 9) so
that the peak drug effect coincided with the third hour
following CFA. The concentration of yohimbine used was
based on previous reports of effective intrathecal α-2
adrenoceptor blockade (Ossipov et al. 1989; Takano &
Yaksh, 1992; Green et al. 1998). At the time of injection the
tip of a 100μl Hamilton syringewas inserted into the PE10
tubing and 10 μl of the drug was delivered over several
minutes. This was washed through with an equivalent
volume of saline. In a separate group of animals (n = 6),
the non-specific opioid antagonist naloxone (3mg kg−1 in
0.9% saline) (cat. no. N7758; Sigma-Aldrich Co. Ltd) was
delivered I.P. so that the peak drug effect coincided with
the second hour following CFA.
At the end of the experiment the position of the
cannula was determined by injecting 20 μl of xylocaine
(2%) through the cannula. If pinch-evoked EMG activity
was abolished, the cannula was deemed to be correctly
positioned; if not, the data were not included in sub-
sequent analyses (n = 1, CFA injected). Additionally, in
some experiments the location of the distal tip of the
catheter was determined by injection of pontamine Sky
Blue (20μl of 5%) and visual confirmation of the location
of the catheter tip.
Statistical analyses
Data are displayed as the mean ± S.E.M. unless otherwise
noted in figure legends. Data were analysed using
Graphpad PrismVersion 4/5 (GraphPad Software, Inc., La
Jolla, CA, USA) using theMann–Whitney test (two-group
comparisons) or Kruskal–Wallis test, one- or two-way
ANOVA (three or more groups) as appropriate and as
stated in figure legends.
Results
Consequences of CFA-induced inflammation of the
hairy skin of the rat hind foot
Injection of 50μg CFA into the hind foot dorsum resulted
in foot oedema that was evident after 1 h and persisted for
7 days (baseline, 4.2 ± 0.1 mm vs. 7 days, 6.3 ± 0.2 mm;
P < 0.001) (Fig. 2A). CFA also produced a mechanical
hyperalgesia to a noxious pinch (baseline, 87± 33 gmm–2
vs. 7 days, 39 ± 5 g mm−2; P < 0.05) (Fig. 2B), but did
not induce a thermal hyperalgesia in hairy skin (baseline,
49 ± 1.1°C; 3 h, 49 ± 2.3°C; 24 h, 47 ± 1.3°C; 3 days,
51± 1.0°C) (Fig. 2C). An equivalent S.C. injection of CFA
into the plantar surface of the hind foot resulted in thermal
hyperalgesia that persisted for at least 3 days (baseline,
47 ± 0.9°C vs. 3 days, 42 ± 1.2°C; P < 0.05) (Fig. 2D).
The ability of the thermal ramp stimuli to pre-
ferentially activate A- and C- nociceptors is reliant on
the achievement of subsurface cutaneous heating rates of
2.5°C s−1 (fast) for A-nociceptors and 0.8°C s−1 (slow) for
C-nociceptors (Yeomans&Proudfit, 1996;McMullan et al.
2004;McMullan&Lumb, 2006a; Leith et al. 2007). As limb
oedema could affect the heat transfer through the skin, and
thus subcutaneous heating rates, we first determined the
effect of acute inflammatoryoedemaoncutaneousheating
rates. Surface heating rates elicited by both fast and slow
heating rampswere kept within limits previously shown to
elicit correct subsurface heating rates in normal skin (fast:
– 7.5°C s−1; slow – 2.5°C s−1) (McMullan et al. 2004) and
the corresponding subsurface heating rates were recorded.
Subsurface heating rates to both fast and slow thermal
ramps were unchanged over the 3 h of acute inflammation
(P > 0.05) (Fig. 3). However, at 7 days following CFA,
subsurface heating rates elicited by slow thermal ramps
were significantly faster than pre-CFA values (baseline
subsurface rate, 0.6 ± 0.03°C s−1 vs. 7 day subsurface
rate, 1.2 ± 0.1°C s−1; P < 0.05) (Fig. 3).
Effect of CFA-induced inflammation on the spinal
processing of thermal nociceptor inputs from hairy
and glabrous skin
We sought to determine the effects of CFA-induced
inflammation of hairy skin on the spinal processing
of A- and C-nociceptor inputs. Withdrawal thresholds
to thermal A- and C-nociceptor stimulation were both
significantly lower at 1 h after CFA injection (baseline
A-nociceptors vs. 1 h A-nociceptors, 57 ± 0.8°C vs.
45 ± 0.9°C; P < 0.001) (Fig. 4A) (baseline C-nociceptors
vs. 1 h C-nociceptors, 53 ± 0.4°C vs. 40 ± 1.8°C;
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P< 0.001) (Fig. 4B). After 2 h, the withdrawal threshold to
C-nociceptor stimulation had returned to slightly above
baseline levels (baseline vs. 2 h, 53± 0.4°C vs. 54± 2.0°C)
(Fig. 4B), whereas A-nociceptor thresholds were still
lowered (baseline vs. 2 h, 57 ± 0.8°C vs. 49 ± 2.0°C;
P < 0.001) (Fig. 4A). By 3 h, A- and C-nociceptor
thresholds had returned to baseline values (P > 0.05)
(Fig. 4A and B). Vehicle injection had no significant effect
on A- or C-nociceptor thresholds (P > 0.05) (Fig. 4A
and B). It should be noted that in three of five animals,
at 2 h and 3 h following CFA, no EMG activity to
C-nociceptor stimulation was evoked before stimulation
reached the imposed cut-off temperature. Furthermore,
in two additional animals (data not shown and not used
in further analysis) the cut-off was not imposed and
in these animals we found thresholds for withdrawal
Figure 2. A single S.C. injection of
complete Freund’s adjuvant (CFA) into
the hind foot dorsum leads to a primary
mechanical but not thermal hyperalgesia
A, delivery of CFA (50 μl) into the hind foot
dorsum produced significant oedema
[one-way repeated-measures (RM) ANOVA,
P < 0.0001, F(4,3) = 33.54; Bonferroni’s
post-test, ∗P < 0.001 compared with
baseline; n = 4]. B, CFA-induced
inflammation was associated with a primary
mechanical hyperalgesia (one-way RM
ANOVA, P < 0.001, F(3,3) = 7.13;
Bonferroni’s post-test, ∗P < 0.05 compared
with baseline; n = 4). C, CFA-induced
inflammation did not, however, result in
thermal hyperalgesia (n = 4). D, by contrast,
a 50 μl S.C. injection of CFA into the plantar
surface of the hind foot produced a
persistent primary thermal hyperalgesia
(one-way RM ANOVA, P < 0.05,
F(3,2) = 11.88; Bonferroni’s post-test,
∗P < 0.05 compared with baseline; n = 3).
Figure 3. A single S.C. injection of complete Freund’s adjuvant (CFA) into the hind foot dorsum does not
affect the subcutaneous heating rates required to preferentially activate A- and C-nociceptors during
acute inflammation
A, acute (1–3 h) or more chronic (7 days) CFA-induced inflammation of the dorsal hind foot did not affect
the ability of fast surface ramps to deliver subcutaneous heating rates to preferentially activate A-nociceptors.
B, acute inflammation did not affect the ability of slow surface ramps to deliver subcutaneous heating rates
to preferentially activate C-nociceptors (Kruskal–Wallis test, P > 0.05; n = 3 both groups). However, 7 days
following CFA, subsurface rates delivered by slow ramps were slightly but significantly faster than in naı¨ve animals
(Kruskal–Wallis test, P < 0.05; Dunn’s multiple comparison test, ∗P < 0.05; n = 3).
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to C-nociceptor activation to be greater than 60°C.
By contrast, thresholds of withdrawal to A-nociceptor
activation were always below the imposed temperature
cut-off.
Doubling the amount of injected CFA resulted in
significantly less sensitization of the reflex pathway over
the 3 h period (Fig. 4C and D). Compared with the
50 μg dose, a 100 μg CFA injection caused similar
reduction in the A-nociceptor withdrawal threshold at
1 h, but surprisingly significantly less reduction in the
C-nociceptor threshold at this time (50μg at 1 h vs. 100μg
at 1 h, 40± 1.8°C vs. 51± 1.0°C; P < 0.001) (Fig. 4D). At
2 h, both C- and A-nociceptor withdrawal thresholds had
returned to baseline values and A-nociceptor withdrawal
thresholds were significantly higher than threshold values
for the 50 μg dose at the same time-point (50 μl at 2 h
vs. 100 μl at 2 h, 49 ± 2.0°C vs. 55 ± 1.4°C; P < 0.05)
(Fig. 4C).
Although CFA is known to produce persistent afferent
sensitization lasting days or weeks (Ren & Dubner, 1999),
following dorsal CFA we found thermal nociceptive
behaviour to be unchanged at 3 days (Fig. 2). Additionally,
at 7 days after CFA injection, withdrawal thresholds to
A- and C-nociceptor activation were also unchanged
(C-nociceptor naı¨ve vs. C-nociceptor 7 day CFA,
53± 0.6°C. vs. 55± 2.0°C;Mann–Whitney test, P > 0.05;
n = 4; A-nociceptor naı¨ve vs. A-nociceptor 7 day CFA,
58 ± 0.5°C vs. 58 ± 0.6°C; Mann–Whitney test, P > 0.05;
n = 4, not shown). By contrast, although the withdrawal
threshold did increase slightly towards baseline over 3 h,
injection of CFA into the glabrous skin of the plantar
hind foot resulted in a significant reduction in withdrawal
thresholds to the thermal stimulus for the 3 h studied
(P < 0.05 at all time-points) (Fig. 5). It has been pre-
viously shown that S.C.CFAdelivered to theplantar surface
of the foot leads to thermal hyperalgesia lasting >1 week
Figure 4. A single S.C. injection of complete Freund’s adjuvant (CFA) into the hind foot dorsum produces
a transient sensitization of withdrawal reflexes to A- and C-nociceptor activation
A, CFA-induced inflammation of the dorsal hind foot resulted in a transient reduction in the withdrawal threshold
to A-nociceptor stimulation that resolved fully by 3 h after CFA injection [one-way repeated-measures (RM) ANOVA,
P < 0.0001, F(3,4) = 21.22; Bonferroni’s post-test, ∗∗∗P < 0.001 compared with baseline; n = 5]. B, responses
to C-nociceptor activation showed that inflammation resulted in an even more transient response, resolving
after 2 h (one-way RM ANOVA, P < 0.0001, F(3,4) = 20.39; Bonferroni’s post-test, ∗P < 0.001 compared with
baseline; n = 5). An equivalent injection of vehicle (mineral oil) had no significant effect on withdrawal thresholds
to A- or C-nociceptor activation (mineral oil group, Friedman test, P > 0.05; n = 3). C, a larger dose of CFA
(100 μg/100 μl) resulted in a more rapid resolution of sensitization to A-nociceptor activation, causing a more
rapid return to baseline (two-way RM ANOVA, main dose effect, P = 0.08, F(3,1) = 3.98; Bonferroni’s post-test,
∗P < 0.05 between groups; n = 5 for both groups). D, a larger dose of CFA (100μg) resulted in a more rapid
resolution of sensitization to C-nociceptor activation so that withdrawal thresholds were significantly higher than
with a 50 μg dose at the 1 h time-point (two-way RM ANOVA, main dose effect, P = 0.0022, F(3,1) = 19.53;
Bonferroni’s post-test, ∗∗∗P < 0.001 between groups; n = 5 for both groups).
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(Ren & Dubner, 1999). Differences in sensitization may
be attributable to differences in inflammatory reaction
and/or oedema. There was significantly greater swelling
in the plantar surface of the hind foot 3 h after
injection of CFA comparedwith the dorsal surface (dorsal,
5.9 ± 0.2 mm, n = 7; plantar, 6.9 ± 0.2 mm, n = 6;
P < 0.05) (Fig. 6). The degree of swelling of the hind foot
did not differ significantly after injection of 100 μg CFA,
compared with 50μg CFA injected into the dorsal surface
(3 h 100 μg dorsal, 6 ± 0.2 mm, n = 5) (Fig. 6).
Effect of spinal α-2-adrenoceptor receptor blockade
on the processing of thermal nociceptor inputs during
hind foot inflammation
Following inflammation of hairy skin, the observation
of sensitization followed by a reversal over minutes or
hours suggested that descending inhibitory mechanisms
may affect spinal processing in acute inflammation.
Intrathecal delivery of the α-2-adrenoceptor antagonist,
yohimbine (30 μg in 10 μl) (Takano & Yaksh, 1992;
Green et al. 1998; Hughes et al. 2013), 2 h after
CFA, when thresholds had returned (C-nociceptors) or
were returning (A-nociceptors) to baseline, significantly
inhibited the reversal of both A- and C-nociceptor
withdrawal thresholds (3 h A-nociceptor CFA only vs.
3 h A-nociceptor CFA + yohimbine, 55 ± 1.3°C vs.
50 ± 0.9°C; P < 0.05) (Fig. 7A) (3 h C-nociceptor CFA
only vs. 3 hC-nociceptorCFA+ yohimbine, 55± 1.1°C vs.
Figure 5. Sensitization resulting from acute inflammation of
the plantar hind foot is unaffected by intrathecal yohimbine
Acute complete Freund’s adjuvant (CFA)-induced inflammation of
the plantar hind foot resulted in a reduction in thermal withdrawal
threshold that persisted for the 3 h tested [one-way
repeated-measures (RM) ANOVA, P < 0.0001, F(3,4) = 19.30;
Bonferroni’s post-test, ∗∗∗P < 0.001, ∗∗P < 0.01 compared with
baseline]. This was unaffected by intrathecal yohimbine at 3 h
following CFA (n = 5 CFA, n = 4 CFA + yoh).
47±2.3°C;P<0.05) (Fig. 7B). By contrast, yohimbinedid
not affect the withdrawal to thermal stimulation applied
to inflamed glabrous skin (Fig. 5), which was apparent
at 1 h and was maintained for the 3 h studied (CFA
only 3 h threshold vs. CFA + yohimbine 3 h withdrawal
threshold, 47 ± 0.7°C vs. 47 ± 0.4°C (Fig. 5). Intrathecal
delivery of the same volume of vehicle did not affect
withdrawal thresholds in either experiment (n = 3 for
both experiments; data not shown).
Spinal and supraspinal opioidergic systems are known
to have robust inhibitory effects on spinal nociceptive
processing during inflammation (Stanfa & Dickenson,
1995; Przewłocki & Przewłocka, 2001). We therefore
also determined the contribution of opioidergic systems
to the degree of hyperalgesia in acute hind foot
CFA inflammation. Systemic delivery of the pan-opioid
receptor antagonist naloxone (3 mg kg−1) (Stanfa
& Dickenson, 1995) had no effect on either A- or
C-nociceptor withdrawal thresholds in hairy skin at either
2 h or 3 h following CFA (Fig. 7C and D). It has been pre-
viously shown that naloxone has no effect on withdrawal
latencies to thermal stimuli at 4 h following plantar
inflammation (Hylden et al. 1991; Tsuruoka & Willis,
1996).
Discussion
Two key observations arise from these data: (i) there is a
differential descending noradrenergic inhibitory control
Figure 6. Foot swelling is different following complete
Freund’s adjuvant (CFA) injection into the dorsal or plantar
hind foot
Injection of 50 μg CFA resulted in greater swelling in the plantar
than the dorsal surface of the hind foot. Injection of a larger CFA
concentration (100 μg) in the dorsal surface did not increase the
swelling above that caused by 50 μg (one-way ANOVA, P < 0.0001,
F(12,70) = 59.13; Bonferroni post hoc tests, ∗P < 0.05 plantar cf.
both other groups; data shown as mean ± S.D.).
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on different skin types in acute inflammation, and (ii)
there is a greater descending inhibitory control of C- than
A-nociceptor evoked reflexes from hairy skin.
Subcutaneous injection of CFA is a well characterized
and widely utilized cutaneous inflammatory model,
primarily used to study inflammatory hypersensitivity
in glabrous (plantar) skin (Iadarola et al. 1988; Ren &
Dubner, 1999). The oedema generated in glabrous or hairy
skin is not equivalent for the same dose of CFA (Cook &
Moore, 2006), but as CFA produces a dose-dependent
inflammatory response (Donaldson et al. 1993) that
should be equivalent at different sites, inflammation
of hairy and glabrous skin might be predicted to
induce equivalent primary hyperalgesia. The literature
reports that CFA injection results in a robust primary
mechanical and, usually, following plantar injection,
thermal behavioural hypersensitivity to stimulation from
as early as 1 h, which reportedly lasts for weeks (Iadarola
et al. 1988; Ren & Dubner, 1999; Terayama et al. 2002;
Soignier et al. 2011). Plantar inflammation also results
in mechanical hypersensitivity (Ren & Dubner, 1999;
Cook & Moore, 2006; Soignier et al. 2011). By contrast,
dorsal (hairy) hind foot inflammation results in no change
in the thermal reflex withdrawal response, despite the
thermal sensitization of single peripheral nociceptors
in the same model (Dunham et al. 2008; Koerber
et al. 2010). CFA-induced inflammation results in robust
longlasting peripheral nociceptor thermal sensitization
in rats, guinea pigs and primates (Kocher et al. 1987;
Davis et al. 1993; Andrew & Greenspan, 1999; Djouhri
& Lawson, 1999; Djouhri et al. 2001; Dunham et al.
2008; Koerber et al. 2010), irrespective of whether hairy
or glabrous skin is inflamed, which is inconsistent with
the behavioural data. We therefore determined whether
the observed lack of thermal behavioural responses in
acute inflammation might be attributable to descending
inhibitory control ofnociceptiveprocessing from inflamed
hairy skin sites.Theobservation thatplantar inflammation
produces greater swelling, but little obvious descending
inhibition, whereas dorsal inflammation produces less
swelling but more profound inhibition with increasing
severity of inflammation suggests that it is the overall
degree of inflammation, rather than just the oedema,
that engages descending control systems. This is consistent
with previous findings, in which much higher CFA doses
produced acute thermal analgesia (i.e. less nociception
than control) in hairy but not glabrous skin (Cook &
Moore, 2006). Therefore, differences in inflammatory
oedema in different sites may not accurately predict
nociceptive responses as this aspect of inflammation may
more accurately reflect local tissue compliance (Reed &
Rubin, 2010) rather than nociceptive input.
Processing of noxious inputs is known to be sub-
ject to both descending inhibitory and facilitatory
controls (Millan, 2002; Vanegas & Schaible, 2004).
Primary inflammatory hyperalgesia is widely accepted as
Figure 7. Blockade of spinal α-2
adrenoceptors reveals a rapid
inhibitory control on withdrawal
reflexes to A- and C-nociceptor
activation during acute inflammation
A, the loss of acute sensitization to
A-nociceptor stimulation 3 h after
complete Freund’s adjuvant (CFA) injection
was partially reversed by the intrathecal
injection of the noradrenergic α-2 receptor
antagonist yohimbine [Mann–Whitney U
test, ∗P < 0.05; n = 7 CFA (3 h), n = 5
yoh]. B, the loss of acute sensitization to
C-nociceptor stimulation 3 h after CFA
injection was reversed by yohimbine
[Mann–Whitney U test, ∗P < 0.05; n = 8
CFA (3 h), n = 5 yoh]. C, D, systemic
administration of the pan-opioid
antagonist, naloxone, had no effect on
either A-nociceptor evoked withdrawals
(CFA, n = 5; CFA + nal, n = 6) (C) or
C-nociceptor evoked withdrawals (CFA,
n = 5; CFA + nal, n = 6) (D).
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being dominated by descending inhibitory controls, which
are both rapidly activated and longlasting. These are
hypothesized to protect against spinal hyperexcitability
following inflammation by limiting mechanisms of
central sensitization (Ren & Dubner, 1996; Vanegas &
Schaible, 2004). However, they are not usually reported to
completely obliterate the nociceptive sensitivity resulting
from the insult (Tsuruoka & Willis, 1996; Tsuruoka et al.
2003; Vanegas & Schaible, 2004). This contrasts with our
findings, in which thermal hyperalgesia in hairy skin was
more short-lived, particularly so when inflammation was
more severe (100 μg CFA dose).
Descending fibres from areas such as the LC and
RVM exert profound modulatory influences on spinal
nociceptive processing (Fields et al. 1991; Tsuruoka &
Willis, 1996; Miki et al. 2002; Millan, 2002; Tsuruoka et al.
2003) throughmonoaminergic systems (Pertovaara, 2006;
Yoshimura & Furue, 2006). Descending monoaminergic
systems, particularly noradrenaline acting through spinal
α-2 receptors, are reported to modulate the development
of inflammatory hyperalgesia (Tsuruoka & Willis, 1996;
Tsuruoka et al. 2003; Pertovaara, 2006). Our findings
confirm this for hairy cutaneous tissue and additionally
indicate that, at acute time-points, yohimbine blockade
modulates thermal inflammatory sensitivity differentially
in hairy and glabrous skin.
It has been proposed that the descending noradrenergic
systems form a stimulus-driven negative feedback circuit
that impinges onto spinal nociceptive processing and
so regulates the onward flow of ascending nociceptive
information (Pertovaara, 2006, 2013). Our finding of a
greater inhibition in more severe inflammation in hairy
skin would support this. By contrast, in glabrous skin
hypersensitivity persists (>4 h) (Tsuruoka &Willis, 1996)
and at acute time-points (<3 h) we find little evidence
of either monoaminergic or opioidergic inhibition,
consistent with previous findings (Hylden et al. 1991;
Tsuruoka & Willis, 1996).
Although yohimbine has high affinity for α-2 receptors
and is commonly used as a specific α-2-adrenoceptor
antagonist, it has moderate affinity at α-1-adrenoceptors,
5-HT1A, 5-HT1B and dopamine D2 receptors [Ki
determinations generously provided by the National
Institute of Mental Health’s Psychoactive Drug Screening
Program (http://pdsp.med.unc.edu/pdsp.php)]. As a
result of the latter effects, systemic yohimbine can
decrease 5-HT and increase dopamine and noradrenaline
levels in rat CNS, probably through blockade of auto-
receptors (Paalzow & Paalzow, 1983; Millan et al. 2000).
In inflammation, spinal 5-HT1A receptors both enhance
(Zhang et al. 2001; Wang et al. 2003) and inhibit
(Liu et al. 2002; Yu et al. 2011; Horiguchi et al.
2013) acute inflammatorynociception; knowndescending
5-HT3 receptor-mediated facilitatory pathways do not
seem to contribute to inflammatory nociception (Asante
& Dickenson, 2010). There are no published data
on contributions of spinal D2 receptors to acute
inflammatory nociception. Although this concentration
of yohimbine administered intrathecally has been widely
interpreted as exerting actions primarily at α-2 adreno-
ceptors (Ossipov et al. 1989; Takano & Yaksh, 1992; Green
et al. 1998; De Felice et al. 2011; Hughes et al. 2013), we
cannot exclude an additional contribution of modulation
of α-1-adreno or 5-HT receptors at the spinal level to the
observed effects of yohimbine. Actions of yohimbine on
5-HT1A receptors would be consistent with a concurrent
antinociceptive effect of 5-HT in this model (Liu et al.
2002; Yu et al. 2011; Horiguchi et al. 2013).
The nocifensive flexor reflex is thought to provide an
objective measure of noxious threshold and is the most
commonly used in pain studies in both humans and
animals (Wiesenfeld-Hallin, 1995; Sandrini et al. 2005).
In animals the nocifensive flexor reflex typically involves
recording EMG activity from the biceps femoris evoked
by stimulation of the hind limb (Wiesenfeld-Hallin,
1995). α-Motor neurons serving the biceps femoris have
receptive fields on both the dorsal and plantar surfaces
(Cook & Woolf, 1985) and thus the effects of drugs
on reflexes evoked from both foot surfaces can be
directly compared and contrasted. Thus, although the
musculotopic organization of reflexes may have meant
that recording from different muscular sites may have
yielded slightly different results (Schouenborg et al. 1994;
Harris & Clarke, 2002), these may not have been directly
comparable for stimulation of different sites on the
hind limb. In addition, as α-2-adrenoceptor agonists are
analgesic (Pertovaara, 2006) and presumably inhibit the
sensory afferent arm of the withdrawal reflex, it could
be hypothesized that the result of yohimbine blockade
would affect, to a greater or lesser extent, all muscle groups
involved in noxious withdrawal reflexes. This is supported
by the behavioural data.
A differential descending inhibitory control on glabrous
versus hairy skin may relate to the functional importance
of the footpad/glabrous skin.Theplantar surface forms the
main exploratory hind foot surface in rodents, providing
important sensory and discriminative information about
the environment (Boada et al. 2013). Pain provides
a critical protective mechanism in which nociceptive
sensitization, including increased reflex sensitivity, serves
to protect injured areas that might regularly come into
contact with physical stimuli (Schouenborg et al. 1994)
and it has been shown that load-bearing parts of the foot
have special significance in generating reflex sensitization
(Clarke & Harris, 2004). However, effective locomotion
is essential to survival, being central to feeding and
escape behaviours, and therefore the positive impact
of nociceptive reflex hypersensitivity and its protective
function must be traded against its negative impact on
locomotion. Thus peripheral domains that rarely come
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into contact with nociceptive stimuli (dorsal hind foot)
mayhave a reduced capacity toproduce reflex sensitization
following inflammation.
The differences in descending inhibition of spinal
processing of afferent input from different peri-
pheral domains may also represent a difference in
both innervation and the effects of inflammation
on innervating neuronal properties. The inflammatory
sensitization of unmyelinated afferents differs in glabrous
versushairy skin in both the rat and the primate (Campbell
& Meyer, 1983; Kocher et al. 1987; Andrew & Greenspan,
1999; Dunham et al. 2008) in that peripheral thermal
sensitization occurs in C-nociceptors innervating hairy
skin (Campbell &Meyer, 1983; Davis et al. 1993; Dunham
et al. 2008; Koerber et al. 2010), but not in glabrous
skin (Meyer & Campbell, 1981; Campbell & Meyer,
1983; Andrew & Greenspan, 1999; Du et al. 2006), in
which C-nociceptors may become desensitized instead
(Campbell & Meyer, 1983; Andrew & Greenspan, 1999).
C-nociceptors play critical roles in driving mechanisms
of central sensitization and of descending controls from
supraspinal sites (Woolf &Wall, 1986; Sivilotti et al. 1993;
Suzuki et al. 2002; Ikeda et al. 2003; Mantyh & Hunt,
2004; You et al. 2010). Sensitization of C-nociceptors in
inflamed hairy skin would drive ascending and therefore
alsodescending systems to a greater extent than in glabrous
skin, in which C-nociceptors do not readily sensitize,
leading to the differences in inhibition observed. This
is supported by the enhanced inhibition seen in a more
severe inflammation, in which nociceptors are sensitized
more rapidly and afferent barrage is greater (Fig. 4C and
D).
Previous findings from our laboratory indicate that
descending inhibitory controls arising from the PAG
preferentially target C-nociceptive inputs to spinal
nociceptive networks (McMullan & Lumb, 2006b). Here,
during acute inflammation of hairy skin, we observe
a fast-acting and potent inhibition of C-nociceptor
evoked withdrawals: at 2 h and 3 h following CFA the
withdrawal thresholds to C-nociceptor stimulation were
greater than baseline values and three of five animals
displayed no evoked EMG activity before the cut-off
temperature was reached. Additionally, in the two cases
in which the cut-off was removed, thresholds for EMG
activity were >60°C (data not shown). By contrast, at
2 h following CFA, thresholds for A-nociceptor evoked
withdrawals were still significantly lower than base-
line values and, at 3 h following CFA, all five animals
responded to the thermal stimuli before the cut-off
temperature was reached. It is likely that the effect of
yohimbine on C- versus A-nociceptor evoked withdrawals
failed to reach significance (data not shown) as a result
of the inherent underestimation of the full effect of
yohimbine onC-nociceptor withdrawal thresholds caused
by the imposed temperature cut-off (55°C). Descending
inhibitory systemshave been shown topreferentially target
thermal spinal nociceptive processing in both normal and
inflamed rats (Kauppila et al. 1998; Howorth et al. 2009),
which is consistent with our observations. Additionally, as
noxiousmechanical stimuli are thought to be conveyed by
A-fibre nociceptors (Ziegler et al. 1999;Magerl et al. 2001),
an alternative interpretation of these findings is that there
is a preferential inhibition of spinal nociceptive processing
of C- versus A-nociceptor inputs.
There may be a possible evolutionary advantage
of greater inhibitory control on C- compared with
A-nociceptor evoked reflexes, which may relate to the
different functions of these afferents. In humans, rapidly
conducting A-nociceptors convey sharp, well-localized,
painful sensations (Magerl et al. 2001), informationwhich
is encoded with high fidelity by spinal neurons (in the
rat) (McMullan & Lumb, 2006a). By contrast, slowly
conducting C-nociceptors convey dull and diffuse pain
(Ziegler et al. 1999; Magerl et al. 2001) encoded with low
fidelity by spinal neurons in rats (McMullan & Lumb,
2006a). Thus A-nociceptors are hypothesized to convey
more detailed information relating to the protective
function of pain (i.e. localization and magnitude
assessment). A greater acute inhibition of C-nociceptor
inputs may serve to filter extraneous C-nociceptive
information and limit saturation in the reflex pathway
(Tsuruoka et al. 2012) while concurrently preserving
A-nociceptive information, which is essential to the
protective function of reflexwithdrawals. Thus differential
inhibitory control of inputs from body areas with
different functions and from different nociceptor types
would be hypothesized to limit central sensitization
and protect against spinal hyperexcitability following
inflammation, whilst maintaining adequate locomotor
and protective nociceptive function to enable healing and
survival.
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